Patent Assignment
Reel/Frame 052326/0409
Assignment of Assignor's Interest
Recorded: 2020-04-07
Pages: 8
Assignors
GALVIN, GABRIEL
Executed: 2020-03-31
SCHAAB, KEVIN
Executed: 2020-04-02
YANIK, MATHEW
Executed: 2020-03-11
Assignee
INTERCEPT PHARMACEUTICALS, INC.
10 HUDSON YARDS, 37TH FLOOR, NEW YORK, NEW YORK, 10001
Covered Properties
(3)
Isotopically Labeled Bile Acid Derivatives
Patent:
11,472,831 →
Application:
16/632,093 →
Publication:
US 2020/0165290
PCT:
PCT/US2018/043239 ↗
Isotopically Labeled Bile Acid Derivatives
Application:
62/536,326 →
Isotopically Labeled Bile Acid Derivatives
Application:
62/536,609 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Aug 18, 2021
From: INTERCEPT PHARMACEUTICALS, INC.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 057650/0772 →
Change of Address
Aug 22, 2022
From: INTERCEPT PHARMACEUTICALS, INC.
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 061297/0990 →
Release of Security Interest
Jan 4, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
To: INTERCEPT PHARMACEUTICALS, INC.
Reel/Frame 066662/0210 →